Pivotal bioVenture Partners Investment Advisor as of March 31, 2023
Portfolio Holdings for Pivotal bioVenture Partners Investment Advisor
Pivotal bioVenture Partners Investment Advisor holds 11 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 58.5 | $142M | 782k | 181.64 | |
| Vaxcyte (PCVX) | 10.7 | $26M | 693k | 37.48 | |
| Inozyme Pharma (INZY) | 7.6 | $18M | 3.2M | 5.73 | |
| Oculis Holding Ordinary Shares (OCS) | 7.3 | $18M | 2.4M | 7.43 | |
| Rallybio Corp (RLYB) | 5.7 | $14M | 2.4M | 5.71 | |
| Arcutis Biotherapeutics (ARQT) | 2.6 | $6.3M | 569k | 11.00 | |
| Fusion Pharmaceuticals | 2.4 | $5.9M | 1.6M | 3.77 | |
| Vigil Neuroscience (VIGL) | 2.3 | $5.5M | 561k | 9.79 | |
| Exscientia Ads (EXAI) | 1.7 | $4.1M | 772k | 5.30 | |
| Bolt Biotherapeutics (BOLT) | 1.1 | $2.6M | 1.9M | 1.39 | |
| Aligos Therapeutics (ALGS) | 0.3 | $650k | 743k | 0.87 |
